
    
      To investigate the efficacy of a nutritional supplement among ARV-na√Øve, asymptomatic HIV
      positive patients with a CD4 count in the range 300-550 cells/ul.

      A total of 120 participants will be stratified by age and gender and randomly assigned to two
      treatment arms. Sixty (60) participants will be assigned to receive dietary counselling and a
      multivitamin/mineral supplement, with sixty (60) additionally receiving an oral Medical
      Nutritional Supplement (MNS).

      Participants will be followed for six months post-randomization: at baseline, 3 months and 6
      months. The principal outcome measure is Body Mass Index, used as a proxy for 'nutritional
      status'. Secondary outcome measures include immune status and antioxidant status.
    
  